Cellectar Biosciences, Inc. ( CLRB) - Key Metrics
CLRB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.57 | -$0.49 | -$0.49 |
| 2026Q1 | $0 | -$1.33 | -$1.14 | -$1.14 |
| 2025Q4 | $0 | -$1.25 | -$1.02 | -$1.03 |
| 2025Q3 | $0 | -$1.41 | -$1.35 | -$1.35 |
| 2025Q2 | $0 | -$3.39 | -$3.18 | -$3.18 |
CLRB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.22 |
| 2026Q1 | 0% | -0.48 |
| 2025Q4 | 0% | -0.59 |
| 2025Q3 | 0% | -0.99 |
| 2025Q2 | 0% | -0.52 |
CLRB
Price: $1.18
52 week price:
Earnings Per Share: -2.21 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 27300
Ebitda: -3.4 millionMarket Capitalization: 14.2 million